Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
102.56
-1.93 (-1.85%)
Jul 28, 2026, 1:49 PM EDT - Market open
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $5.61 billion as of July 28, 2026. Its market cap has increased by 710.85% in one year.
Market Cap
5.61B
Enterprise Value
4.36B
1-Year Change
710.85%
Ranking
Category
Stock Price
$102.56
ChartMarket Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $5.61B, an increase of 3,339.72%. That is a compound annual growth rate of 242.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 5.61B | 217.31% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 6.30B |
| Xenon Pharmaceuticals | 6.23B |
| Erasca | 6.17B |
| Belite Bio | 6.11B |
| PTC Therapeutics | 6.10B |
| Ligand Pharmaceuticals | 5.86B |
| Scholar Rock Holding | 5.71B |
| Definium Therapeutics | 5.39B |